Our Promise: One pill, one bottle, one prescription, one refill, one dispensing fee, one co-pay, once-a-day.

Scientific Advisory Board

Elsayed Z. Soliman, MD, MSc, MS, FAHA, FACC.

Professor of Cardiology and Epidemiology, Wake Forest University, Winston-Salem, NC

Dr. Soliman is a renowned physician-scientist with extensive expertise in epidemiology, public health, education, and clinical research. Over the past 20 years, he has dedicated himself to academic pursuits that encompass research, administration, teaching, and advocacy.

Currently, Dr. Soliman holds a tenured Professorship in Cardiology and Epidemiology at Wake Forest School of Medicine in Winston Salem, NC. Additionally, he serves as the director of the Wake Forest Epidemiological Cardiology Research Center (EPICARE), which is a pioneering institution in population electrocardiography and cardiovascular epidemiology. Dr. Soliman’s contributions to cardiovascular epidemiology and public health are numerous, and his more than 600 peer-reviewed publications in leading medical journals attest to this fact. He is credited with developing novel models and markers to diagnose and predict cardiovascular diseases.

Before joining Wake Forest University School of Medicine, Dr. Soliman served as a Medical Advisor to the Malawi government under the auspices of the Egyptian Fund for Technical Cooperation with Africa. He also worked as a United Nations Medical Doctor (UNV) in Trinidad and Tobago and served as an Adviser to the World Health Organization (WHO), leading two WHO-sponsored studies in Malawi and one in Sri Lanka. Dr. Soliman has chaired and served on several US research working groups and funding organizations, which is a testament to his vast multidisciplinary expertise.

Carlos M. Ferrario, M.D., FACA, FACC

Winston-Salem, NC

Dr. Ferrario pioneered research in the renin-angiotensin system, one of which led to his famous discovery of the function of angiotensin-(1-7) and ACE-2.

Experience
Dr. Carlos M. Ferrario is Professor of Physiology and Pharmacology Director, Hypertension and Vascular Research Center at Wake Forest University in Winston-Salem, NC. He graduated from the University of Buenos Aires Medical School in 1963. After his postgraduate training in cardiology at the University of Geteborg and the Karolinska Institute in Sweden, he joined the Cleveland Clinic Foundation in 1966.

At the Cleveland Clinic Foundation, he was under the mentorship of Dr. Irvine H. Page, a pioneer in hypertension research. There, he developed his promising career and held numerous important positions such as the Chairman of Cardiovascular Research. He also pioneered research in the renin-angiotensin system, one of which led to his famous discovery of the function of angiotensin-(1-7) and ACE-2. In 1992, Dr. Ferrario assumed the directorship of the Hypertension and Vascular Disease Center of the Wake Forest University School of Medicine.

Dr. Ferrario has published over 500 papers, 3 books, and 74 book chapters. Just from that, one can easily imagine the degree of dedication to the advancement of cardiovascular research.

DAVID S.H. BELL, M.D., F.A.C.E.

Birmingham, AL

Dr. Bell is a leading authority on the prevention and treatment of type 2 diabetes.

Experience

David S.H. Bell is a native of Northern Ireland where he graduated from Queens University Medical School. After immigrating to Canada and further training in endocrinology, 2 years in private practice and 2 years on faculty at Temple University Medical School, Dr. Bell joined the faculty at the University of Alabama Medical School where he was a Professor of Medicine for 25 years before retirement to private practice in 2005.

Dr. Bell has published over 310 articles in referenced medical journals and 4 books including Diet For Life the story of his own weight loss. He is also a reviewer for many general medicine and endocrine journals, has served on multiple editorial boards and has delivered invited lectures in Italy, Ireland, England, Canada, Australia, New Zealand, India, Singapore, Korea, Taiwan, Malaysia, the Philippines, Puerto Rico, Denmark, Spain and Portugal. He has been active in many clinical interventional trials for the treatment of diabetes and its complications. In addition, his clinical abilities have been recognized by his peers with his inclusion in the “Best Doctors in America” and America’s Top Doctors, since 2001 as well as Best Doctors for men in Men’s Health in 2007 and Best Doctors for women in Women’s Health in 2008 and USA Today listed him in Most Influential Doctors in Diabetes and Lipids . In 2012 he was, on the recommendation of his patients, included in America’s Most Compassionate Doctors. In 2001 he was presented the Distinguished Clinician award by the American College of Endocrinology for outstanding contributions as a master educator and clinician, and in 2002 the Seale Harris Award by the Southern Medical Association for superior contributions to the art and science of diabetes and endocrinology.

JAMES D. OTVOS, PH.D.

Strategic Director, NMR Diagnostics

Dr Otvos received a PhD. in comparative biochemistry from UC Berkeley and postdoctoral training in molecular biophysics at Yale University.

Experience

Dr Otvos received a PhD. in comparative biochemistry from the University of California-Berkeley and postdoctoral training in molecular biophysics at Yale University.

He spent the following 20 years in academia, first on the chemistry faculty of the University of Wisconsin-Milwaukee and then as Professor of Biochemistry at North Carolina State University during which time he developed new technology for measuring lipoprotein particles using nuclear magnetic resonance (NMR) spectroscopy. He then founded LipoScience, Inc. to enable clinical translation of the NMR blood testing technology and served on the Board of Directors and as Chief Scientific Officer overseeing analytical development and clinical research. Following LabCorp’s acquisition of LipoScience in 2014, Dr Otvos continues to oversee research devoted to development of novel NMR metabolomic assays addressing cardiovascular, diabetes, and inflammatory risk in collaboration with many academic, government, and industrial clinical investigators.

Dr Otvos maintains academic affiliations with NC State University (Adjunct Professor of Molecular and Structural Biochemistry) and the University of North Carolina at Chapel Hill (Adjunct Professor of Medicine). He has coauthored over 180 scientific publications, is a named inventor on over 15 patents, and has received several research awards from the American Association of Clinical Chemistry as well as the Christopher Columbus Foundation/Discover Magazine award for Technological Innovation.